CR10158A - N-sulfonilación selectiva de alcoholes 2-amino trifluoroalquilo sustituidos - Google Patents

N-sulfonilación selectiva de alcoholes 2-amino trifluoroalquilo sustituidos

Info

Publication number
CR10158A
CR10158A CR10158A CR10158A CR10158A CR 10158 A CR10158 A CR 10158A CR 10158 A CR10158 A CR 10158A CR 10158 A CR10158 A CR 10158A CR 10158 A CR10158 A CR 10158A
Authority
CR
Costa Rica
Prior art keywords
methylmorpholine
trifluoroalquilo
sulfonilación
selectiva
alcoholes
Prior art date
Application number
CR10158A
Other languages
English (en)
Inventor
Anita Wai-Yin Chan
Ren Jianxin
Mousumi Ghosh
Panolil Raveendranath
Original Assignee
Dsfasdf
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsfasdf, Wyeth Corp filed Critical Dsfasdf
Publication of CR10158A publication Critical patent/CR10158A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se proveen procedimientos para la preparación de derivados N-(2-hidroxialquilo) heteroareno- y bencensulfonamida trifluoroalquilo sustituidos de fórmula (I) o fórmula (II) ( en donde las variables se definen en las reivindicaciones) y comprenden hacer reaccionar un amino alcohol sustituido con trifluoroalquilo, un cloruro de sulfonilo y un sistema de base/solvente seleccionado del grupo que consiste en (a) 4-metilmorfolina/acetato de isopropilo, (b) base de Hünig/tetrahidrofurano, (c) 4-metilmorfolina/acetonitrillo, (d) 4- metilmorfolina/propionitrilo y (e) 4-metilmorfolina/tolueno.
CR10158A 2006-02-17 2008-07-17 N-sulfonilación selectiva de alcoholes 2-amino trifluoroalquilo sustituidos CR10158A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77430006P 2006-02-17 2006-02-17

Publications (1)

Publication Number Publication Date
CR10158A true CR10158A (es) 2008-10-29

Family

ID=38124142

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10158A CR10158A (es) 2006-02-17 2008-07-17 N-sulfonilación selectiva de alcoholes 2-amino trifluoroalquilo sustituidos

Country Status (18)

Country Link
US (1) US7838550B2 (es)
EP (1) EP1984347A1 (es)
JP (1) JP2009527476A (es)
KR (1) KR20080094685A (es)
CN (1) CN101384579A (es)
AR (1) AR059517A1 (es)
AU (1) AU2007217966A1 (es)
BR (1) BRPI0707742A2 (es)
CA (1) CA2637615A1 (es)
CR (1) CR10158A (es)
EC (1) ECSP088684A (es)
GT (1) GT200800154A (es)
IL (1) IL192929A0 (es)
NO (1) NO20083488L (es)
PE (1) PE20080109A1 (es)
RU (1) RU2008131051A (es)
TW (1) TW200732295A (es)
WO (1) WO2007098030A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002357333B2 (en) 2001-12-20 2008-02-28 Bristol-Myers Squibb Company Alpha-(N-sulphonamido)acetamide derivatives as Beta-amyloid inhibitors
CN101274926A (zh) * 2003-03-31 2008-10-01 惠氏公司 β淀粉样蛋白生成抑制剂含氟和三氟烷基杂环磺酰胺及其衍生物
US7550629B2 (en) * 2006-04-21 2009-06-23 Wyeth Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors
US7476762B2 (en) * 2006-04-21 2009-01-13 Wyeth Methods for preparing sulfonamide compounds
PA8789601A1 (es) * 2007-07-16 2009-02-09 Wyeth Corp Proceso para la preparación de trifluoralquil-fenil sulfonamidas y de sulfonamidas heterocíclicas
WO2009012203A1 (en) * 2007-07-16 2009-01-22 Wyeth Processes and intermediates for the preparation of heterocyclic sulfonamide compounds
CL2008002060A1 (es) * 2007-07-16 2008-11-21 Wyeth Corp Compuestos derivados de sulfonamida, inhibidores de la produccion de beta amiloide; metodo de preparacion; composicion farmaceutica; kit farmaceutico; y uso en el tratamiento de enfermedades tales como alzheimer, angiopatia amiloide, sindrome de down, entre otras.
US8084477B2 (en) 2007-10-31 2011-12-27 Bristol-Myers Squibb Company Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
US8093276B2 (en) * 2007-10-31 2012-01-10 Bristol-Myers Squibb Company Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
EP2278878A4 (en) * 2008-05-08 2014-08-27 Bristol Myers Squibb Co 2-ARYL-GYCINAMID DERIVATIVES
US8044077B2 (en) 2009-03-19 2011-10-25 Bristol-Myers Squibb Company Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production
US7977362B2 (en) 2009-03-20 2011-07-12 Bristol-Myers Squibb Company Alpha-(N-benzenesulfonamido)cycloalkyl derivatives
US20110071199A1 (en) * 2009-03-20 2011-03-24 Bristol-Myers Squibb Company Thiophenyl Sulfonamides for the Treatment of Alzheimer's Disease
US8252821B2 (en) * 2009-04-14 2012-08-28 Bristol-Myers Squibb Company Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound
TW201043269A (en) * 2009-04-14 2010-12-16 Bristol Myers Squibb Co Bioavailable compositions of amorphous alpha-(N-sulfonamido)acetamide compound

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795890A (en) 1995-09-27 1998-08-18 Ono Pharmaceutical Co., Ltd. Sulfonamide derivatives
JPH09241262A (ja) 1996-03-08 1997-09-16 Kao Corp ３−オキサ−２，７−ジアザビシクロ〔３．３．０〕オクタン誘導体
US5962231A (en) 1997-09-30 1999-10-05 Incyte Pharmaceuticals, Inc. Human glutathione-S-transferase
HRP20020585B1 (hr) 1997-11-12 2013-02-28 Bayer Schering Pharma Aktiengesellschaft 2-fenil supstituirani imidazotriazinoni kao inhibitori fosfodiesteraze
JPH11343279A (ja) 1998-03-16 1999-12-14 Shionogi & Co Ltd スルホンアミド誘導体およびそれらを含有するＴＮＦ―α産生抑制剤
GB9805520D0 (en) 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
DE19827640A1 (de) 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
BR0017043A (pt) 1999-12-24 2003-01-07 Bayer Ag Imidazo[1,3,5]triazinonas e sua aplicação
AU2841801A (en) 1999-12-24 2001-07-09 Bayer Aktiengesellschaft Triazolotriazinones and the use thereof
SG128491A1 (en) 2000-12-13 2007-01-30 Wyeth Arqule Inc Heterocyclic sulfonamide inhibitors of beta amyloid production
US6657070B2 (en) 2000-12-13 2003-12-02 Wyeth Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
HUP0402522A2 (hu) 2001-12-11 2005-03-29 Wyeth Eljárás királisan tiszta béta-amino-alkoholok előállítására
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
US7288547B2 (en) 2002-03-11 2007-10-30 Schering Ag CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
AU2003212282A1 (en) 2002-03-11 2003-09-22 Schering Aktiengesellschaft Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
KR20050010882A (ko) 2002-06-11 2005-01-28 와이어쓰 베타 아밀로이드 생산의 치환 페닐술폰아미드 저해제
WO2004078731A1 (en) 2003-03-06 2004-09-16 'chemical Diversity Research Institute', Ltd. Quinoline-carboxylic acids and the derivatives thereof, a focused library
CN101274926A (zh) * 2003-03-31 2008-10-01 惠氏公司 β淀粉样蛋白生成抑制剂含氟和三氟烷基杂环磺酰胺及其衍生物
AU2005207835A1 (en) 2004-01-16 2005-08-11 Wyeth Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
CA2641013A1 (en) * 2006-02-17 2007-08-30 Wyeth Methods for preparing sulfonamide substituted alcohols and intermediates thereof

Also Published As

Publication number Publication date
ECSP088684A (es) 2008-09-29
KR20080094685A (ko) 2008-10-23
RU2008131051A (ru) 2010-03-27
NO20083488L (no) 2008-09-05
JP2009527476A (ja) 2009-07-30
CA2637615A1 (en) 2007-08-30
IL192929A0 (en) 2009-02-11
TW200732295A (en) 2007-09-01
GT200800154A (es) 2008-10-21
PE20080109A1 (es) 2008-04-01
US7838550B2 (en) 2010-11-23
WO2007098030A1 (en) 2007-08-30
EP1984347A1 (en) 2008-10-29
US20070197800A1 (en) 2007-08-23
AR059517A1 (es) 2008-04-09
BRPI0707742A2 (pt) 2011-05-10
AU2007217966A1 (en) 2007-08-30
WO2007098030A8 (en) 2007-10-25
CN101384579A (zh) 2009-03-11

Similar Documents

Publication Publication Date Title
ECSP088684A (es) N-sulfonilacion selectiva de alcoholes 2-amino trifluoroalquilo sustituidos
AR059518A1 (es) Metodos para preparar alcoholes sustituidos con sulfonamidas y sus compuestos intermedios
AR062677A1 (es) Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden
UY26695A1 (es) Activadores para amino sustituidos de la fenilamida glucoquinasa
EA200970605A1 (ru) Ингибиторы mapk/erk-киназ
ECSP077271A (es) Derivados de pirimidina
ECSP077259A (es) Derivados de pirimidina
DK1712547T3 (da) Bicycloesterderivat
CR9221A (es) Procesos para preparar eteres aromaticos
UY29047A1 (es) Derivados de sulfonamidas, su preparación y su aplicación en terapéutica
BRPI0413151A (pt) derivados de amino propanol
PE20070009A1 (es) Tigeciclina y metodos para su preparacion
ES2535033T3 (es) Derivados de 5,6 dihidroxi isoindol como conectores para la síntesis de oligómeros en fase sólida
ATE431333T1 (de) Amino-propanolderivate
AR058348A1 (es) Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden
CY1111432T1 (el) Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5
TR200301248A2 (tr) Antibiyotik Aktiviteye Sahip Olan Farmasotik Kompozisyonlar.
ES2422161T3 (es) Procedimiento para producir 1-(3,4-diclorobencil)-5-octilbiguanida o una sal de la misma
PA8542201A1 (es) Inhibidores de pcp basados en acidos-3-heterociclilpropanohidroxamicos
EA201000566A1 (ru) Гетероциклические сетр ингибиторы
AR051341A1 (es) Proceso para la preparacion de derivados de [1,4,5]-oxadiazepina
DE602006019732D1 (de) Indolylmaleimidderivate
ATE504289T1 (de) Ausstossflüssigkeit und ausstossverfahren
CY1114798T1 (el) Ενωσεις σουλφοναμιδιου για τη θεραπευτικη αντιμετωπιση αναπνευστικων διαταραχων
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)